• EDC.HCl: Practical Coupling Workflow Guide

  2026-09-04

  EDC.HCl is a water-soluble carbodiimide coupling reagent for activating carboxyl groups and supporting amide bond formation with primary amines in peptide, bioconjugation, and related in vitro workflows. This dossier-based guide covers preparation, QC, and troubleshooting; the reagent should not be used for in vivo or clinical applications without separate validation.

• Surrogate BBB Model Corrects Lysosomal Trapping

  2026-09-03

  Hu and colleagues developed a high-throughput LLC-PK1-MOCK/MDR1 Transwell model that combines barrier integrity, P-glycoprotein efflux, bidirectional permeability, and correction for lysosomal drug sequestration. Its correlation with unbound brain distribution and validation across structurally diverse compounds support its use for early CNS candidate prioritization, while also defining important limits for translation to the neurovascular unit.

• c-Myc Peptide: From Assay Control to Translation

  2026-09-02

  A translational perspective on using the c-Myc tag Peptide to validate immunoassay specificity, protect mechanistic inference, and connect assay design with broader transcription-factor research without overstating biological or clinical conclusions.

• Bovine Ovarian Quality, Redox Imbalance, and Apoptosis

  2026-09-02

  This study shows that simple morphology-based classification of bovine ovaries into high- and low-quality groups corresponds to coordinated oxidative imbalance and apoptotic activation in ovarian tissue, follicular fluid, and granulosa cells. Its main practical contribution is a multi-compartment framework in which granulosa-cell measurements provide a particularly sensitive functional readout for interpreting variability in cattle assisted reproductive technology studies.

• Ceramides Drive RGNNV Replication Through Autophagy

  2026-09-01

  This study uses global lipidomics and targeted perturbation experiments to show that red-spotted grouper nervous necrosis virus reshapes ceramide metabolism and uses ceramide accumulation to support replication. The results connect three ceramide-producing pathways with virus-induced autophagy and identify C16-ceramide as a functional mediator, providing a mechanistic framework for antiviral research in aquaculture.

• Honokiol-Induced Paraptosis in Acute Promyelocytic Leukemia

  2026-09-01

  The reference study shows that honokiol can kill NB4 acute promyelocytic leukemia cells through paraptosis-like, caspase-independent damage rather than conventional apoptosis. Its mechanistic contribution is to connect endoplasmic reticulum stress, proteasome impairment, mitochondrial injury, mTOR signaling, and MAPK activation while cautioning that LC3 and p62 accumulation alone does not prove autophagy.

• Calpain, BDNF/TrkB, and Offspring Cognition

  2026-08-31

  A 2025 Neuropharmacology study links maternal non-obstetric surgery during pregnancy to later offspring cognitive deficits through excessive calpain activity and impaired hippocampal BDNF/TrkB signaling. Its pharmacological rescue experiments with MDL 28170 and a TrkB agonist connect protease dysregulation with synaptic structure, neuronal integrity, and behavior, while also defining important limits for translation.

• Dacarbazine A2197: Reliable Cytotoxicity Workflows

  2026-08-31

  This scenario-driven guide explains how Dacarbazine SKU A2197 can support more reproducible viability, proliferation, and cytotoxicity experiments. It connects solvent selection, storage, assay timing, and interpretation to the distinction between relative and fractional viability described in the cited cancer-methods research.

• PP2A, Autophagy, and Candida Biofilm Resistance

  2026-08-30

  A 2025 study identifies PP2A, encoded in part by PPH21, as a regulator of autophagy-linked biofilm formation and antifungal resistance in Candida albicans. Through a PPH21 deletion model, rapamycin stimulation, cellular assays, and an oral infection model, the authors connect Atg13 phosphorylation and Atg1 activation with treatment failure in biofilm-associated infection.

• Matrine Workflows for Thymoma and Inflammation

  2026-08-29

  Matrine supports a practical, multi-endpoint workflow spanning thymoma stemness, apoptosis, cancer signaling, and inflammatory injury models. This guide connects dose planning with assay controls and troubleshooting while separating published observations from testable mechanistic hypotheses.

• Cardiogreen for Imaging and Phototherapy

  2026-08-28

  Cardiogreen, also known as Indocyanine green, connects near-infrared vascular imaging with controlled cell and phototherapy experiments. This guide covers cardiac output measurement, liver blood flow assessment, ophthalmic angiography, and assay designs for apoptosis induction in photodynamic therapy and macrophage-focused tumor studies.

• Murine RNase Inhibitor for RNA Workflows

  2026-08-28

  Murine RNase Inhibitor provides oxidation-resistant protection for RT-qPCR, cDNA synthesis, and in vitro transcription when low DTT is preferred. Its defined specificity as an RNase A inhibitor also makes it valuable for troubleshooting nuclease contamination without broadly suppressing unrelated ribonucleases.

• FMT Reduces Cell Death After Ischemic Stroke

  2026-08-27

  This rat study links fecal microbiota transplantation with improved neurological function, smaller infarcts, and reduced neuronal apoptosis, necroptosis, and inflammatory microglial activation after ischemic stroke. Its main contribution is a multi-level analysis connecting functional outcomes with RIP1/RIP3/MLKL signaling, apoptotic markers, and iNOS-positive microglia, while also highlighting the need for mechanistic and translational validation.

• AM 281 and the Translational Logic of CB1 Blockade

  2026-08-27

  AM 281 offers a selective pharmacological route to interrogate CB1 signaling, astrocytic GLT-1 regulation, glutamate excitotoxicity, and cognitive dysfunction. This thought-leadership guide connects receptor pharmacology with translational strategy for traumatic brain injury, addiction, and memory impairment research.

• Perphenazine: Dopamine D2 Receptor Antagonist

  2026-08-26

  Perphenazine is a dopamine D2 receptor antagonist with additional histamine, muscarinic, and adrenergic receptor activity. Research applications include schizophrenia research, opioid tolerance suppression, mitochondria-mediated cell death induction, and host-directed antibacterial studies.

8513 records 1/568 page Next 12345 下5页 Last page